Bristol Myers Squibb to Report Results for Fourth Quarter 2021 on February 4, 2022
17 Dezembro 2021 - 8:59AM
Business Wire
Bristol Myers Squibb (NYSE:BMY) will announce results for the
fourth quarter of 2021 on Friday, February 4, 2022. During a
conference call at 8 a.m. ET on February 4, 2022, company
executives will review financial results and address inquiries from
investors and analysts.
Investors and the general public are invited to listen to a live
webcast of the call at http://investor.bms.com or by using this
link which becomes active 15 minutes prior to the scheduled start
time and entering your information to be connected. Investors and
the public can also access the live webcast by dialing in the U.S.
toll free 877-502-9276 or international +1 313-209-4906,
confirmation code: 2150568. Materials related to the call will be
available at the same website prior to the conference call.
A replay of the webcast will be available on
http://investor.bms.com approximately three hours after the
conference call concludes. A replay of the conference call will be
available beginning at 11:30 a.m. ET on February 4 through 11:30
a.m. ET on February 18, 2022 by dialing in the U.S. toll free
888-203-1112 or international +1 719-457-0820, confirmation code:
2150568.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211217005052/en/
Media: media@bms.com
Investors: Nina Goworek, 908-673-9711,
nina.goworek@bms.com
Bristol Myers Squibb (NYSE:BMY)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Bristol Myers Squibb (NYSE:BMY)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024